Provention Bio Inc
PRVB·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$8.37
Today
+0.0%
YTD
+0.0%
About
Founded in 2016, Provention Bio is a clinical-stage biopharmaceutical company. It focusses on the development of novel therapeutics to intercept and prevent immune-mediated diseases. Operating within the US, the company has headquarters in Red Bank, New Jersey. It is listed on the NASDAQ GS stock market using the ticker PRVB.Identify the best time to buy by following PRVB share price movements with your eToro watchlist.
Price chart
Closing price history for PRVB (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-16.32
P/S (TTM)169.32
P/B (TTM)17.97
Market cap$2.37B
Cap tierMid-cap
Industry avg P/E-43.36
Profitability
Gross margin86.72%
EBIT margin-993.88%
Net margin-307.75%
ROE-97.66%
ROA-60.98%
Earnings & Revenue
Revenue (TTM)$12.89M
Revenue growth (1Y)+824.4%
EPS (TTM)-$1.53
Free cash flow$-76.20M
Total debt$24.06M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.19
Employees174
Next earnings4 May '23
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.